Lumos Pharma

Lumos Pharma, headquartered in Austin, Texas, is an early-stage biotechnology company focused on developing and commercializing a novel therapy for the rare disease Creatine Transporter Deficiency (CTD). Lumos Pharma is the exclusive licensee of technology and discoveries from laboratories at the University of Cincinnati and collaborates with Key Opinion Leaders in the field as well as the National Institutes of Health to ensure the successful development of treatments for Creatine Transporter Deficiency.